Supra-additive effect of chronic inflammation and atherogenic dyslipidemia on developing type 2 diabetes among young adults: a prospective cohort study

Both elevated inflammation and atherogenic dyslipidemia are prominent in young-onset diabetes and are increasingly identified as biologically intertwined processes that contribute to diabetogenesis. We aimed to investigate the age-specific risks of type 2 diabetes (T2D) upon concomitant chronic infl...

Full description

Saved in:
Bibliographic Details
Published inCardiovascular diabetology Vol. 22; no. 1; p. 181
Main Authors Lan, Yulong, Wu, Dan, Cai, Zhiwei, Xu, Yuancheng, Ding, Xiong, Wu, Weiqiang, Lan, Shaocong, Chen, Lan, Guo, Zheng, Balmer, Lois, Li, Xingang, Song, Manshu, Wu, Shouling, Gao, Jingli, Wang, Wei, Chen, Youren
Format Journal Article
LanguageEnglish
Published England BioMed Central 15.07.2023
BMC
Subjects
Age composition
Age groups
Aging
Antihypertensives
Atherosclerosis - complications
Atherosclerosis - diagnosis
Atherosclerosis - epidemiology
Blood pressure
Body mass index
C-reactive protein
Cohort analysis
Creatinine
Diabetes
Diabetes mellitus (non-insulin dependent)
Diabetes Mellitus, Type 2 - diagnosis
Diabetes Mellitus, Type 2 - epidemiology
Dyslipidemia
Dyslipidemias - diagnosis
Dyslipidemias - epidemiology
Epidemiology
Glucose
Humans
Hypertension
Inflammation
Inflammation - complications
Inflammation - diagnosis
Inflammation - epidemiology
Insulin
Kidney diseases
Lipids
Metabolic disorders
Prospective Studies
Renal function
Risk Factors
Trends
Type 2 diabetes
Variables
Young Adult
Young adults
China
Type 2 diabetes
Aging
Inflammation
Young adults
Dyslipidemia
Online AccessGet full text

Cover

Abstract Both elevated inflammation and atherogenic dyslipidemia are prominent in young-onset diabetes and are increasingly identified as biologically intertwined processes that contribute to diabetogenesis. We aimed to investigate the age-specific risks of type 2 diabetes (T2D) upon concomitant chronic inflammation and atherogenic dyslipidemia. Age-stratified Cox regression analysis of the risk of incident diabetes upon co-exposure to time-averaged cumulative high-sensitivity C-reactive protein (CumCRP) and atherogenic index of plasma (CumAIP) among 42,925 nondiabetic participants from a real-world, prospective cohort (Kailuan Study). During a median 6.41 years of follow-up, 3987 T2D developed. Isolated CumAIP and CumCRP were significantly associated with incident T2D in the entire cohort and across all age subgroups. Both CumAIP and CumCRP were jointly associated with an increased risk of diabetes (P-interaction = 0.0126). Compared to CumAIP < -0.0699 and CumCRP < 1 mg/L, co-exposure to CumAIP ≥ - 0.0699 and CumCRP ≥ 3 mg/L had a significant hazard ratio (HR) [2.55 (2.23-2.92)] after adjusting for socio-demographic, life-style factors, family history of diabetes, blood pressure, renal function and medication use. The co-exposure-associated risks varied greatly by age distribution (P-interaction = 0.0193): < 40 years, 6.26 (3.47-11.28); 40-49 years, 2.26 (1.77-2.89); 50-59 years, 2.51 (2.00-3.16); 60-69 years, 2.48 (1.86-3.30); ≥ 70 years, 2.10 (1.29-3.40). In young adults (< 45 years), both exposures had a significant supra-additive effect on diabetogenesis (relative excess risk due to interaction: 0.80, 95% CI 0.10-1.50). These findings highlight the need for age-specific combined assessment and management of chronic inflammation and dyslipidemia in primary prevention against T2D, particularly for young adults. The clinical benefit derived from dual-target intervention against dyslipidemia and inflammation will exceed the sum of each part alone in young adults.
AbstractList Abstract Background Both elevated inflammation and atherogenic dyslipidemia are prominent in young-onset diabetes and are increasingly identified as biologically intertwined processes that contribute to diabetogenesis. We aimed to investigate the age-specific risks of type 2 diabetes (T2D) upon concomitant chronic inflammation and atherogenic dyslipidemia. Methods Age-stratified Cox regression analysis of the risk of incident diabetes upon co-exposure to time-averaged cumulative high-sensitivity C-reactive protein (CumCRP) and atherogenic index of plasma (CumAIP) among 42,925 nondiabetic participants from a real-world, prospective cohort (Kailuan Study). Results During a median 6.41 years of follow-up, 3987 T2D developed. Isolated CumAIP and CumCRP were significantly associated with incident T2D in the entire cohort and across all age subgroups. Both CumAIP and CumCRP were jointly associated with an increased risk of diabetes ( P -interaction = 0.0126). Compared to CumAIP < -0.0699 and CumCRP < 1 mg/L, co-exposure to CumAIP ≥ − 0.0699 and CumCRP ≥ 3 mg/L had a significant hazard ratio (HR) [2.55 (2.23–2.92)] after adjusting for socio-demographic, life-style factors, family history of diabetes, blood pressure, renal function and medication use. The co-exposure-associated risks varied greatly by age distribution ( P -interaction = 0.0193): < 40 years, 6.26 (3.47–11.28); 40–49 years, 2.26 (1.77–2.89); 50–59 years, 2.51 (2.00–3.16); 60–69 years, 2.48 (1.86–3.30); ≥ 70 years, 2.10 (1.29–3.40). In young adults (< 45 years), both exposures had a significant supra-additive effect on diabetogenesis (relative excess risk due to interaction: 0.80, 95% CI 0.10–1.50). Conclusions These findings highlight the need for age-specific combined assessment and management of chronic inflammation and dyslipidemia in primary prevention against T2D, particularly for young adults. The clinical benefit derived from dual-target intervention against dyslipidemia and inflammation will exceed the sum of each part alone in young adults.
BACKGROUNDBoth elevated inflammation and atherogenic dyslipidemia are prominent in young-onset diabetes and are increasingly identified as biologically intertwined processes that contribute to diabetogenesis. We aimed to investigate the age-specific risks of type 2 diabetes (T2D) upon concomitant chronic inflammation and atherogenic dyslipidemia.METHODSAge-stratified Cox regression analysis of the risk of incident diabetes upon co-exposure to time-averaged cumulative high-sensitivity C-reactive protein (CumCRP) and atherogenic index of plasma (CumAIP) among 42,925 nondiabetic participants from a real-world, prospective cohort (Kailuan Study).RESULTSDuring a median 6.41 years of follow-up, 3987 T2D developed. Isolated CumAIP and CumCRP were significantly associated with incident T2D in the entire cohort and across all age subgroups. Both CumAIP and CumCRP were jointly associated with an increased risk of diabetes (P-interaction = 0.0126). Compared to CumAIP < -0.0699 and CumCRP < 1 mg/L, co-exposure to CumAIP ≥ - 0.0699 and CumCRP ≥ 3 mg/L had a significant hazard ratio (HR) [2.55 (2.23-2.92)] after adjusting for socio-demographic, life-style factors, family history of diabetes, blood pressure, renal function and medication use. The co-exposure-associated risks varied greatly by age distribution (P-interaction = 0.0193): < 40 years, 6.26 (3.47-11.28); 40-49 years, 2.26 (1.77-2.89); 50-59 years, 2.51 (2.00-3.16); 60-69 years, 2.48 (1.86-3.30); ≥ 70 years, 2.10 (1.29-3.40). In young adults (< 45 years), both exposures had a significant supra-additive effect on diabetogenesis (relative excess risk due to interaction: 0.80, 95% CI 0.10-1.50).CONCLUSIONSThese findings highlight the need for age-specific combined assessment and management of chronic inflammation and dyslipidemia in primary prevention against T2D, particularly for young adults. The clinical benefit derived from dual-target intervention against dyslipidemia and inflammation will exceed the sum of each part alone in young adults.
Abstract Background Both elevated inflammation and atherogenic dyslipidemia are prominent in young-onset diabetes and are increasingly identified as biologically intertwined processes that contribute to diabetogenesis. We aimed to investigate the age-specific risks of type 2 diabetes (T2D) upon concomitant chronic inflammation and atherogenic dyslipidemia. Methods Age-stratified Cox regression analysis of the risk of incident diabetes upon co-exposure to time-averaged cumulative high-sensitivity C-reactive protein (CumCRP) and atherogenic index of plasma (CumAIP) among 42,925 nondiabetic participants from a real-world, prospective cohort (Kailuan Study). Results During a median 6.41 years of follow-up, 3987 T2D developed. Isolated CumAIP and CumCRP were significantly associated with incident T2D in the entire cohort and across all age subgroups. Both CumAIP and CumCRP were jointly associated with an increased risk of diabetes (P-interaction = 0.0126). Compared to CumAIP < -0.0699 and CumCRP < 1 mg/L, co-exposure to CumAIP ≥ − 0.0699 and CumCRP ≥ 3 mg/L had a significant hazard ratio (HR) [2.55 (2.23–2.92)] after adjusting for socio-demographic, life-style factors, family history of diabetes, blood pressure, renal function and medication use. The co-exposure-associated risks varied greatly by age distribution (P-interaction = 0.0193): < 40 years, 6.26 (3.47–11.28); 40–49 years, 2.26 (1.77–2.89); 50–59 years, 2.51 (2.00–3.16); 60–69 years, 2.48 (1.86–3.30); ≥ 70 years, 2.10 (1.29–3.40). In young adults (< 45 years), both exposures had a significant supra-additive effect on diabetogenesis (relative excess risk due to interaction: 0.80, 95% CI 0.10–1.50). Conclusions These findings highlight the need for age-specific combined assessment and management of chronic inflammation and dyslipidemia in primary prevention against T2D, particularly for young adults. The clinical benefit derived from dual-target intervention against dyslipidemia and inflammation will exceed the sum of each part alone in young adults.
BackgroundBoth elevated inflammation and atherogenic dyslipidemia are prominent in young-onset diabetes and are increasingly identified as biologically intertwined processes that contribute to diabetogenesis. We aimed to investigate the age-specific risks of type 2 diabetes (T2D) upon concomitant chronic inflammation and atherogenic dyslipidemia.MethodsAge-stratified Cox regression analysis of the risk of incident diabetes upon co-exposure to time-averaged cumulative high-sensitivity C-reactive protein (CumCRP) and atherogenic index of plasma (CumAIP) among 42,925 nondiabetic participants from a real-world, prospective cohort (Kailuan Study).ResultsDuring a median 6.41 years of follow-up, 3987 T2D developed. Isolated CumAIP and CumCRP were significantly associated with incident T2D in the entire cohort and across all age subgroups. Both CumAIP and CumCRP were jointly associated with an increased risk of diabetes (P-interaction = 0.0126). Compared to CumAIP < -0.0699 and CumCRP < 1 mg/L, co-exposure to CumAIP ≥ − 0.0699 and CumCRP ≥ 3 mg/L had a significant hazard ratio (HR) [2.55 (2.23–2.92)] after adjusting for socio-demographic, life-style factors, family history of diabetes, blood pressure, renal function and medication use. The co-exposure-associated risks varied greatly by age distribution (P-interaction = 0.0193): < 40 years, 6.26 (3.47–11.28); 40–49 years, 2.26 (1.77–2.89); 50–59 years, 2.51 (2.00–3.16); 60–69 years, 2.48 (1.86–3.30); ≥ 70 years, 2.10 (1.29–3.40). In young adults (< 45 years), both exposures had a significant supra-additive effect on diabetogenesis (relative excess risk due to interaction: 0.80, 95% CI 0.10–1.50).ConclusionsThese findings highlight the need for age-specific combined assessment and management of chronic inflammation and dyslipidemia in primary prevention against T2D, particularly for young adults. The clinical benefit derived from dual-target intervention against dyslipidemia and inflammation will exceed the sum of each part alone in young adults.
Both elevated inflammation and atherogenic dyslipidemia are prominent in young-onset diabetes and are increasingly identified as biologically intertwined processes that contribute to diabetogenesis. We aimed to investigate the age-specific risks of type 2 diabetes (T2D) upon concomitant chronic inflammation and atherogenic dyslipidemia. Age-stratified Cox regression analysis of the risk of incident diabetes upon co-exposure to time-averaged cumulative high-sensitivity C-reactive protein (CumCRP) and atherogenic index of plasma (CumAIP) among 42,925 nondiabetic participants from a real-world, prospective cohort (Kailuan Study). During a median 6.41 years of follow-up, 3987 T2D developed. Isolated CumAIP and CumCRP were significantly associated with incident T2D in the entire cohort and across all age subgroups. Both CumAIP and CumCRP were jointly associated with an increased risk of diabetes (P-interaction = 0.0126). Compared to CumAIP < -0.0699 and CumCRP < 1 mg/L, co-exposure to CumAIP ≥ - 0.0699 and CumCRP ≥ 3 mg/L had a significant hazard ratio (HR) [2.55 (2.23-2.92)] after adjusting for socio-demographic, life-style factors, family history of diabetes, blood pressure, renal function and medication use. The co-exposure-associated risks varied greatly by age distribution (P-interaction = 0.0193): < 40 years, 6.26 (3.47-11.28); 40-49 years, 2.26 (1.77-2.89); 50-59 years, 2.51 (2.00-3.16); 60-69 years, 2.48 (1.86-3.30); ≥ 70 years, 2.10 (1.29-3.40). In young adults (< 45 years), both exposures had a significant supra-additive effect on diabetogenesis (relative excess risk due to interaction: 0.80, 95% CI 0.10-1.50). These findings highlight the need for age-specific combined assessment and management of chronic inflammation and dyslipidemia in primary prevention against T2D, particularly for young adults. The clinical benefit derived from dual-target intervention against dyslipidemia and inflammation will exceed the sum of each part alone in young adults.
ArticleNumber 181
Author Guo, Zheng
Balmer, Lois
Li, Xingang
Wang, Wei
Cai, Zhiwei
Wu, Shouling
Song, Manshu
Chen, Youren
Ding, Xiong
Gao, Jingli
Lan, Shaocong
Lan, Yulong
Wu, Weiqiang
Xu, Yuancheng
Chen, Lan
Wu, Dan
Author_xml – sequence: 1
  givenname: Yulong
  surname: Lan
  fullname: Lan, Yulong
  organization: Department of Cardiology, Second Affiliated Hospital of Shantou University Medical College, 69 Dongxia North Road, Shantou, 515041, China
– sequence: 2
  givenname: Dan
  surname: Wu
  fullname: Wu, Dan
  organization: Department of Pediatrics, Second Affiliated Hospital of Shantou University Medical College, Shantou, 515041, China
– sequence: 3
  givenname: Zhiwei
  surname: Cai
  fullname: Cai, Zhiwei
  organization: Department of Cardiology, Second Affiliated Hospital of Shantou University Medical College, 69 Dongxia North Road, Shantou, 515041, China
– sequence: 4
  givenname: Yuancheng
  surname: Xu
  fullname: Xu, Yuancheng
  organization: Department of Urology, The University of Hong Kong-Shenzhen Hospital, Shenzhen, 518172, China
– sequence: 5
  givenname: Xiong
  surname: Ding
  fullname: Ding, Xiong
  organization: School of Public Health, Wuhan University, Wuhan, 430072, China
– sequence: 6
  givenname: Weiqiang
  surname: Wu
  fullname: Wu, Weiqiang
  organization: Department of Cardiology, Second Affiliated Hospital of Shantou University Medical College, 69 Dongxia North Road, Shantou, 515041, China
– sequence: 7
  givenname: Shaocong
  surname: Lan
  fullname: Lan, Shaocong
  organization: Guangdong Medical University, Zhanjiang, 524023, China
– sequence: 8
  givenname: Lan
  surname: Chen
  fullname: Chen, Lan
  organization: Department of Cardiology, The First Affiliated Hospital of Shantou University Medical College, Shantou, 515041, China
– sequence: 9
  givenname: Zheng
  surname: Guo
  fullname: Guo, Zheng
  organization: Centre for Precision Health, Edith Cowan University, Room 521, Building 21/270 Joondalup Drive, Perth, WA, 6027, Australia
– sequence: 10
  givenname: Lois
  surname: Balmer
  fullname: Balmer, Lois
  organization: Centre for Precision Health, Edith Cowan University, Room 521, Building 21/270 Joondalup Drive, Perth, WA, 6027, Australia
– sequence: 11
  givenname: Xingang
  surname: Li
  fullname: Li, Xingang
  organization: Centre for Precision Health, Edith Cowan University, Room 521, Building 21/270 Joondalup Drive, Perth, WA, 6027, Australia
– sequence: 12
  givenname: Manshu
  surname: Song
  fullname: Song, Manshu
  organization: Beijing Key Laboratory of Clinical Epidemiology, School of Public Health, Capital Medical University, Beijing, 100069, China
– sequence: 13
  givenname: Shouling
  surname: Wu
  fullname: Wu, Shouling
  email: drwusl@163.com
  organization: Department of Cardiology, Kailuan General Hospital, Xinghua East Road, Tangshan, 063000, China. drwusl@163.com
– sequence: 14
  givenname: Jingli
  surname: Gao
  fullname: Gao, Jingli
  email: tsgaojingli@163.com
  organization: Department of Intensive Care Unit, Kailuan General Hospital, Xinghua East Road, Tangshan, China. tsgaojingli@163.com
– sequence: 15
  givenname: Wei
  surname: Wang
  fullname: Wang, Wei
  email: wei.wang@ecu.edu.au, wei.wang@ecu.edu.au, wei.wang@ecu.edu.au
  organization: Beijing Key Laboratory of Clinical Epidemiology, School of Public Health, Capital Medical University, Beijing, 100069, China. wei.wang@ecu.edu.au
– sequence: 16
  givenname: Youren
  surname: Chen
  fullname: Chen, Youren
  email: yrchen3@stu.edu.cn
  organization: Department of Cardiology, Second Affiliated Hospital of Shantou University Medical College, 69 Dongxia North Road, Shantou, 515041, China. yrchen3@stu.edu.cn
BackLink https://www.ncbi.nlm.nih.gov/pubmed/37454077$$D View this record in MEDLINE/PubMed
BookMark eNpdUstu1DAUjVARfcAPsECW2LAJ2I4TO2xQVfGoVIkFsLYc-3rGo8QOtjNSvoTfxTNTqpaFH7rn3HPto3NZnfngoapeE_yeENF9SIT2TVNjWhYRXNTts-qCMN7WVDB89uh-Xl2mtMOYcNGRF9V5w1nLMOcX1Z8fyxxVrYxx2e0BgbWgMwoW6W0M3mnkvB3VNKnsgkfKG6TyFmLYwAE0axrd7AxMTqGCG9jDGGbnNyivMyCKjFMDZEhITaFU17CUXZllzOkjUmiOIc1l4mG2DtsQM0p5MevL6rlVY4JX9-dV9evL55833-q7719vb67vat12LNeC8o4phvsOdAvDwESLMaN2aLjAnFIlAAwTFvrCM6QHioUxzFBlNeHFuavq9qRrgtrJObpJxVUG5eSxEOJGqpidHkEKQjuq-85ga1jHrOBUUCFY22hK1MCK1qeT1rwMExgNPkc1PhF9ini3lZuwlwQ3Lab8oPDuXiGG3wukLCeXNIyj8hCWJKloBGVN35NCffsfdReW6ItXRxYXtGu7wqInli4-pwj24TUEy0OI5ClEslghjyGSbWl68_gfDy3_UtP8BWujxqE
CitedBy_id crossref_primary_10_1136_bmjopen_2023_082957
crossref_primary_10_1186_s12933_024_02330_y
crossref_primary_10_1186_s12933_024_02244_9
crossref_primary_10_1161_JAHA_123_033610
crossref_primary_10_3389_fendo_2024_1360874
Cites_doi 10.2337/dc20-2375
10.1161/STROKEAHA.113.678839
10.1016/j.diabres.2014.04.006
10.1016/S0009-9120(01)00263-6
10.1016/S0140-6736(20)32374-6
10.1038/s41591-019-0675-0
10.1016/j.jacc.2015.11.037
10.1007/s00125-015-3525-8
10.1002/eji.201545502
10.2337/dc17-1116
10.1002/osp4.54
10.1038/nm.3589
10.1016/S2213-8587(21)00045-0
10.1038/s41574-020-0334-z
10.1172/JCI92035
10.2337/dc23-S002
10.1016/j.pec.2010.10.030
10.1161/CIRCULATIONAHA.110.940809
10.1016/0895-4356(90)90060-3
10.1016/j.diabres.2019.107843
10.1016/j.jacc.2020.09.535
10.1161/JAHA.122.025226
10.1097/EDE.0000000000000096
10.1136/bmj.k4641
10.1136/bmj.m997
10.1007/s00125-003-1111-y
10.1038/nrendo.2012.114
10.1038/s41598-021-89307-z
10.1186/s12944-020-01418-0
10.1038/srep41969
10.2337/dc12-2388
10.1038/s41575-021-00448-y
10.1111/j.1749-6632.2000.tb06651.x
10.1001/jamasurg.2016.1130
10.1001/jamacardio.2016.0096
10.1016/j.jacl.2010.02.005
10.1016/j.bbi.2021.12.027
10.1001/jama.2021.4001
10.1371/journal.pone.0061665
10.1038/s41574-018-0059-4
10.1161/CIRCRESAHA.120.317950
10.1210/jc.2008-2844
10.7326/0003-4819-150-9-200905050-00006
10.1016/j.jacc.2017.11.006
10.1001/jamanetworkopen.2022.5012
10.1016/j.numecd.2020.06.026
10.1111/dom.14251
10.1016/j.jacc.2015.03.517
10.1001/jamanetworkopen.2019.4758
10.1016/S0140-6736(13)62154-6
10.1016/j.cmet.2012.04.001
10.1038/s41569-021-00541-4
10.1038/s41581-019-0135-6
10.1016/j.jacc.2021.12.017
ContentType Journal Article
Copyright 2023. The Author(s).
2023. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
The Author(s) 2023
Copyright_xml – notice: 2023. The Author(s).
– notice: 2023. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
– notice: The Author(s) 2023
DBID CGR
CUY
CVF
ECM
EIF
NPM
AAYXX
CITATION
3V.
7T5
7X7
7XB
88E
8FI
8FJ
8FK
ABUWG
AFKRA
AZQEC
BENPR
CCPQU
DWQXO
FYUFA
GHDGH
H94
K9.
M0S
M1P
PIMPY
PQEST
PQQKQ
PQUKI
7X8
5PM
DOA
DOI 10.1186/s12933-023-01878-5
DatabaseName Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
CrossRef
ProQuest Central (Corporate)
Immunology Abstracts
ProQuest - Health & Medical Complete保健、医学与药学数据库
ProQuest Central (purchase pre-March 2016)
Medical Database (Alumni Edition)
Hospital Premium Collection
Hospital Premium Collection (Alumni Edition)
ProQuest Central (Alumni) (purchase pre-March 2016)
ProQuest Central (Alumni)
ProQuest Central UK/Ireland
ProQuest Central Essentials
ProQuest Central
ProQuest One Community College
ProQuest Central Korea
Health Research Premium Collection
Health Research Premium Collection (Alumni)
AIDS and Cancer Research Abstracts
ProQuest Health & Medical Complete (Alumni)
Health & Medical Collection (Alumni Edition)
PML(ProQuest Medical Library)
Publicly Available Content Database
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Academic
ProQuest One Academic UKI Edition
MEDLINE - Academic
PubMed Central (Full Participant titles)
DOAJ Directory of Open Access Journals
DatabaseTitle MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
CrossRef
Publicly Available Content Database
ProQuest Central Essentials
ProQuest One Academic Eastern Edition
ProQuest Health & Medical Complete (Alumni)
ProQuest Central (Alumni Edition)
ProQuest One Community College
ProQuest Hospital Collection
Health Research Premium Collection (Alumni)
ProQuest Hospital Collection (Alumni)
ProQuest Central
ProQuest Health & Medical Complete
Health Research Premium Collection
ProQuest Medical Library
ProQuest One Academic UKI Edition
Health and Medicine Complete (Alumni Edition)
ProQuest Central Korea
AIDS and Cancer Research Abstracts
Immunology Abstracts
ProQuest One Academic
ProQuest Medical Library (Alumni)
ProQuest Central (Alumni)
MEDLINE - Academic
DatabaseTitleList CrossRef
MEDLINE - Academic

Publicly Available Content Database
MEDLINE
Database_xml – sequence: 1
  dbid: DOA
  name: DOAJ Directory of Open Access Journals
  url: https://www.doaj.org/
  sourceTypes: Open Website
– sequence: 2
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 3
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
– sequence: 4
  dbid: 7X7
  name: ProQuest - Health & Medical Complete保健、医学与药学数据库
  url: https://search.proquest.com/healthcomplete
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1475-2840
EndPage 181
ExternalDocumentID oai_doaj_org_article_81262c96d0fd464f8728288453c21ab4
10_1186_s12933_023_01878_5
37454077
Genre Journal Article
GeographicLocations China
GeographicLocations_xml – name: China
GrantInformation_xml – fundername: Guangdong Science and Technology Department
  grantid: 200114175898086
– fundername: National Natural Science Foundation of China
  grantid: NSFC 81561128020-NHMRC APP1112767
– fundername: National Natural Science Foundation of China
  grantid: 81870312
– fundername: Guangdong Science and Technology Department
  grantid: 200114155897353
– fundername: ;
  grantid: NSFC 81561128020–NHMRC APP1112767; 81870312
– fundername: ;
  grantid: 200114175898086; 200114155897353
GroupedDBID ---
-5E
-5G
-A0
-BR
0R~
29B
2WC
3V.
53G
5GY
5VS
6J9
7X7
88E
8FI
8FJ
AAFWJ
AAJSJ
ABDBF
ABUWG
ACGFO
ACGFS
ACIHN
ACIWK
ACPRK
ACRMQ
ADBBV
ADINQ
ADRAZ
ADUKV
AEAQA
AENEX
AFKRA
AFPKN
AFRAH
AHBYD
AHMBA
AHYZX
ALIPV
ALMA_UNASSIGNED_HOLDINGS
AMKLP
AMTXH
AOIJS
BAPOH
BAWUL
BCNDV
BENPR
BFQNJ
BMC
BPHCQ
BVXVI
C24
C6C
CCPQU
CGR
CS3
CUY
CVF
DIK
DU5
E3Z
EAD
EAP
EAS
EBD
EBLON
EBS
ECM
EIF
EMB
EMK
EMOBN
ESX
F5P
FRP
FYUFA
GROUPED_DOAJ
GX1
HMCUK
HYE
IAO
IHR
INH
INR
ITC
KQ8
M1P
M48
M~E
NPM
O5R
O5S
OK1
P2P
PGMZT
PIMPY
PQQKQ
PROAC
PSQYO
RBZ
RNS
ROL
RPM
RSV
SMD
SOJ
SV3
TR2
TUS
UKHRP
W2D
WOQ
WOW
XSB
AAYXX
CITATION
7T5
7XB
8FK
AZQEC
DWQXO
H94
K9.
PQEST
PQUKI
7X8
5PM
ID FETCH-LOGICAL-c564t-82764a4096ec5ebb4850042fb3780722a8eed48fe9764d19e208dd4d2afc17023
IEDL.DBID RPM
ISSN 1475-2840
IngestDate Tue Oct 22 15:02:54 EDT 2024
Tue Sep 17 21:30:31 EDT 2024
Fri Oct 25 10:47:45 EDT 2024
Thu Oct 10 17:44:36 EDT 2024
Thu Sep 12 16:39:17 EDT 2024
Wed Oct 16 00:38:43 EDT 2024
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 1
Keywords Type 2 diabetes
Aging
Inflammation
Young adults
Dyslipidemia
Language English
License 2023. The Author(s).
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c564t-82764a4096ec5ebb4850042fb3780722a8eed48fe9764d19e208dd4d2afc17023
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
OpenAccessLink https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10350274/
PMID 37454077
PQID 2838782656
PQPubID 42570
PageCount 1
ParticipantIDs doaj_primary_oai_doaj_org_article_81262c96d0fd464f8728288453c21ab4
pubmedcentral_primary_oai_pubmedcentral_nih_gov_10350274
proquest_miscellaneous_2838243991
proquest_journals_2838782656
crossref_primary_10_1186_s12933_023_01878_5
pubmed_primary_37454077
PublicationCentury 2000
PublicationDate 2023-07-15
PublicationDateYYYYMMDD 2023-07-15
PublicationDate_xml – month: 07
  year: 2023
  text: 2023-07-15
  day: 15
PublicationDecade 2020
PublicationPlace England
PublicationPlace_xml – name: England
– name: London
PublicationTitle Cardiovascular diabetology
PublicationTitleAlternate Cardiovasc Diabetol
PublicationYear 2023
Publisher BioMed Central
BMC
Publisher_xml – name: BioMed Central
– name: BMC
References MR Taskinen (1878_CR11) 2003; 46
CM Khoo (1878_CR6) 2021; 23
AS Levey (1878_CR34) 2009; 150
G Targher (1878_CR38) 2021; 18
R Latham (1878_CR49) 2022; 101
R Shivakoti (1878_CR47) 2022; 5
D Magliano (1878_CR8) 2020; 16
YX Wang (1878_CR32) 2017; 7
Z Shan (1878_CR36) 2018; 363
M Kato (1878_CR9) 2019; 15
M Dobiásová (1878_CR12) 2001; 34
N Esser (1878_CR41) 2014; 105
C Franceschi (1878_CR20) 2000; 908
P Ridker (1878_CR33) 2016; 67
D Hessler (1878_CR51) 2011; 85
X Pan (1878_CR44) 2021; 9
S Dugani (1878_CR10) 2016; 1
C Barbiellini Amidei (1878_CR7) 2021; 325
Y Park (1878_CR22) 2015; 65
X Ma (1878_CR15) 2020; 19
Z Wang (1878_CR28) 2021; 31
L Aung (1878_CR4) 2016; 151
AR Saltiel (1878_CR40) 2017; 127
YW Li (1878_CR13) 2021; 11
M Zhao (1878_CR5) 2021; 44
CG Magnussen (1878_CR52) 2010; 122
SE Kahn (1878_CR17) 2014; 383
J Chan (1878_CR2) 2021; 396
M Dobiásová (1878_CR16) 2006; 52
1878_CR23
A Pirillo (1878_CR46) 2021; 18
PK Whelton (1878_CR35) 2018; 71
KJ Nadeau (1878_CR24) 2009; 94
TJ VanderWeele (1878_CR37) 2014; 25
J Li (1878_CR48) 2020; 76
C Franceschi (1878_CR45) 2018; 14
Y Li (1878_CR3) 2020; 369
C Glass (1878_CR18) 2012; 15
A Wang (1878_CR30) 2013; 8
L Liberale (1878_CR21) 2022; 79
M Zheng (1878_CR27) 2020; 127
P Saeedi (1878_CR1) 2019; 157
D Furman (1878_CR54) 2019; 25
H Sell (1878_CR19) 2012; 8
T Heidt (1878_CR50) 2014; 20
Y Huang (1878_CR31) 2022; 11
S Wu (1878_CR26) 2019; 2
FM Wensveen (1878_CR39) 2015; 45
B Vergès (1878_CR42) 2015; 58
Q Zhang (1878_CR25) 2013; 44
WH Herman (1878_CR53) 2017; 40
SS Coughlin (1878_CR55) 1990; 43
A Onat (1878_CR14) 2010; 4
NA ElSayed (1878_CR29) 2023; 46
DL Ellsworth (1878_CR43) 2016; 2
References_xml – volume: 44
  start-page: 1426
  issue: 6
  year: 2021
  ident: 1878_CR5
  publication-title: Diabetes Care
  doi: 10.2337/dc20-2375
  contributor:
    fullname: M Zhao
– volume: 44
  start-page: 2451
  issue: 9
  year: 2013
  ident: 1878_CR25
  publication-title: Stroke
  doi: 10.1161/STROKEAHA.113.678839
  contributor:
    fullname: Q Zhang
– volume: 105
  start-page: 141
  issue: 2
  year: 2014
  ident: 1878_CR41
  publication-title: Diabetes Res Clin Pract
  doi: 10.1016/j.diabres.2014.04.006
  contributor:
    fullname: N Esser
– volume: 34
  start-page: 583
  issue: 7
  year: 2001
  ident: 1878_CR12
  publication-title: Clin Biochem
  doi: 10.1016/S0009-9120(01)00263-6
  contributor:
    fullname: M Dobiásová
– volume: 396
  start-page: 2019
  issue: 10267
  year: 2021
  ident: 1878_CR2
  publication-title: Lancet
  doi: 10.1016/S0140-6736(20)32374-6
  contributor:
    fullname: J Chan
– volume: 25
  start-page: 1822
  issue: 12
  year: 2019
  ident: 1878_CR54
  publication-title: Nat Med
  doi: 10.1038/s41591-019-0675-0
  contributor:
    fullname: D Furman
– volume: 67
  start-page: 712
  issue: 6
  year: 2016
  ident: 1878_CR33
  publication-title: J Am Coll Cardiol
  doi: 10.1016/j.jacc.2015.11.037
  contributor:
    fullname: P Ridker
– volume: 58
  start-page: 886
  issue: 5
  year: 2015
  ident: 1878_CR42
  publication-title: Diabetologia
  doi: 10.1007/s00125-015-3525-8
  contributor:
    fullname: B Vergès
– volume: 45
  start-page: 2446
  issue: 9
  year: 2015
  ident: 1878_CR39
  publication-title: Eur J Immunol
  doi: 10.1002/eji.201545502
  contributor:
    fullname: FM Wensveen
– volume: 40
  start-page: 1668
  issue: 12
  year: 2017
  ident: 1878_CR53
  publication-title: Diabetes Care
  doi: 10.2337/dc17-1116
  contributor:
    fullname: WH Herman
– volume: 2
  start-page: 282
  issue: 3
  year: 2016
  ident: 1878_CR43
  publication-title: Obes Sci Pract
  doi: 10.1002/osp4.54
  contributor:
    fullname: DL Ellsworth
– volume: 20
  start-page: 754
  issue: 7
  year: 2014
  ident: 1878_CR50
  publication-title: Nat Med
  doi: 10.1038/nm.3589
  contributor:
    fullname: T Heidt
– volume: 9
  start-page: 373
  issue: 6
  year: 2021
  ident: 1878_CR44
  publication-title: Lancet Diabetes Endocrinol
  doi: 10.1016/S2213-8587(21)00045-0
  contributor:
    fullname: X Pan
– volume: 16
  start-page: 321
  issue: 6
  year: 2020
  ident: 1878_CR8
  publication-title: Nat Rev Endocrinol
  doi: 10.1038/s41574-020-0334-z
  contributor:
    fullname: D Magliano
– volume: 127
  start-page: 1
  issue: 1
  year: 2017
  ident: 1878_CR40
  publication-title: J Clin Invest
  doi: 10.1172/JCI92035
  contributor:
    fullname: AR Saltiel
– volume: 46
  start-page: S19
  issue: Suppl 1
  year: 2023
  ident: 1878_CR29
  publication-title: Diabetes Care.
  doi: 10.2337/dc23-S002
  contributor:
    fullname: NA ElSayed
– volume: 85
  start-page: 154
  issue: 2
  year: 2011
  ident: 1878_CR51
  publication-title: Patient Educ Couns
  doi: 10.1016/j.pec.2010.10.030
  contributor:
    fullname: D Hessler
– volume: 122
  start-page: 1604
  issue: 16
  year: 2010
  ident: 1878_CR52
  publication-title: Circulation
  doi: 10.1161/CIRCULATIONAHA.110.940809
  contributor:
    fullname: CG Magnussen
– volume: 43
  start-page: 87
  issue: 1
  year: 1990
  ident: 1878_CR55
  publication-title: J Clin Epidemiol
  doi: 10.1016/0895-4356(90)90060-3
  contributor:
    fullname: SS Coughlin
– volume: 157
  year: 2019
  ident: 1878_CR1
  publication-title: Diabetes Res Clin Pract
  doi: 10.1016/j.diabres.2019.107843
  contributor:
    fullname: P Saeedi
– volume: 76
  start-page: 2181
  issue: 19
  year: 2020
  ident: 1878_CR48
  publication-title: J Am Coll Cardiol
  doi: 10.1016/j.jacc.2020.09.535
  contributor:
    fullname: J Li
– volume: 11
  issue: 15
  year: 2022
  ident: 1878_CR31
  publication-title: J Am Heart Assoc
  doi: 10.1161/JAHA.122.025226
  contributor:
    fullname: Y Huang
– volume: 25
  start-page: 711
  issue: 5
  year: 2014
  ident: 1878_CR37
  publication-title: Epidemiology
  doi: 10.1097/EDE.0000000000000096
  contributor:
    fullname: TJ VanderWeele
– volume: 363
  year: 2018
  ident: 1878_CR36
  publication-title: BMJ
  doi: 10.1136/bmj.k4641
  contributor:
    fullname: Z Shan
– volume: 369
  year: 2020
  ident: 1878_CR3
  publication-title: BMJ
  doi: 10.1136/bmj.m997
  contributor:
    fullname: Y Li
– volume: 46
  start-page: 733
  issue: 6
  year: 2003
  ident: 1878_CR11
  publication-title: Diabetologia
  doi: 10.1007/s00125-003-1111-y
  contributor:
    fullname: MR Taskinen
– volume: 8
  start-page: 709
  issue: 12
  year: 2012
  ident: 1878_CR19
  publication-title: Nat Rev Endocrinol
  doi: 10.1038/nrendo.2012.114
  contributor:
    fullname: H Sell
– volume: 11
  start-page: 9900
  issue: 1
  year: 2021
  ident: 1878_CR13
  publication-title: Sci Rep
  doi: 10.1038/s41598-021-89307-z
  contributor:
    fullname: YW Li
– volume: 19
  start-page: 240
  issue: 1
  year: 2020
  ident: 1878_CR15
  publication-title: Lipids Health Dis
  doi: 10.1186/s12944-020-01418-0
  contributor:
    fullname: X Ma
– volume: 7
  start-page: 41969
  year: 2017
  ident: 1878_CR32
  publication-title: Sci Rep
  doi: 10.1038/srep41969
  contributor:
    fullname: YX Wang
– ident: 1878_CR23
  doi: 10.2337/dc12-2388
– volume: 18
  start-page: 599
  issue: 9
  year: 2021
  ident: 1878_CR38
  publication-title: Nat Rev Gastroenterol Hepatol
  doi: 10.1038/s41575-021-00448-y
  contributor:
    fullname: G Targher
– volume: 908
  start-page: 244
  year: 2000
  ident: 1878_CR20
  publication-title: Ann N Y Acad Sci.
  doi: 10.1111/j.1749-6632.2000.tb06651.x
  contributor:
    fullname: C Franceschi
– volume: 151
  start-page: 798
  issue: 9
  year: 2016
  ident: 1878_CR4
  publication-title: JAMA Surg
  doi: 10.1001/jamasurg.2016.1130
  contributor:
    fullname: L Aung
– volume: 1
  start-page: 136
  issue: 2
  year: 2016
  ident: 1878_CR10
  publication-title: JAMA Cardiol
  doi: 10.1001/jamacardio.2016.0096
  contributor:
    fullname: S Dugani
– volume: 4
  start-page: 89
  issue: 2
  year: 2010
  ident: 1878_CR14
  publication-title: J Clin Lipidol
  doi: 10.1016/j.jacl.2010.02.005
  contributor:
    fullname: A Onat
– volume: 101
  start-page: 78
  year: 2022
  ident: 1878_CR49
  publication-title: Brain Behav Immun
  doi: 10.1016/j.bbi.2021.12.027
  contributor:
    fullname: R Latham
– volume: 52
  start-page: 64
  issue: 1
  year: 2006
  ident: 1878_CR16
  publication-title: Vnitr Lek
  contributor:
    fullname: M Dobiásová
– volume: 325
  start-page: 1640
  issue: 16
  year: 2021
  ident: 1878_CR7
  publication-title: jama
  doi: 10.1001/jama.2021.4001
  contributor:
    fullname: C Barbiellini Amidei
– volume: 8
  issue: 4
  year: 2013
  ident: 1878_CR30
  publication-title: PLoS ONE
  doi: 10.1371/journal.pone.0061665
  contributor:
    fullname: A Wang
– volume: 14
  start-page: 576
  issue: 10
  year: 2018
  ident: 1878_CR45
  publication-title: Nat Rev Endocrinol
  doi: 10.1038/s41574-018-0059-4
  contributor:
    fullname: C Franceschi
– volume: 127
  start-page: 1491
  issue: 12
  year: 2020
  ident: 1878_CR27
  publication-title: Circ Res
  doi: 10.1161/CIRCRESAHA.120.317950
  contributor:
    fullname: M Zheng
– volume: 94
  start-page: 3687
  issue: 10
  year: 2009
  ident: 1878_CR24
  publication-title: J Clin Endocrinol Metab
  doi: 10.1210/jc.2008-2844
  contributor:
    fullname: KJ Nadeau
– volume: 150
  start-page: 604
  issue: 9
  year: 2009
  ident: 1878_CR34
  publication-title: Ann Intern Med
  doi: 10.7326/0003-4819-150-9-200905050-00006
  contributor:
    fullname: AS Levey
– volume: 71
  start-page: e127
  issue: 19
  year: 2018
  ident: 1878_CR35
  publication-title: J Am Coll Cardiol
  doi: 10.1016/j.jacc.2017.11.006
  contributor:
    fullname: PK Whelton
– volume: 5
  issue: 3
  year: 2022
  ident: 1878_CR47
  publication-title: JAMA Netw Open
  doi: 10.1001/jamanetworkopen.2022.5012
  contributor:
    fullname: R Shivakoti
– volume: 31
  start-page: 102
  issue: 1
  year: 2021
  ident: 1878_CR28
  publication-title: Nutr Metab Cardiovasc Dis
  doi: 10.1016/j.numecd.2020.06.026
  contributor:
    fullname: Z Wang
– volume: 23
  start-page: 299
  issue: 2
  year: 2021
  ident: 1878_CR6
  publication-title: Diabetes Obes Metab
  doi: 10.1111/dom.14251
  contributor:
    fullname: CM Khoo
– volume: 65
  start-page: 2091
  issue: 19
  year: 2015
  ident: 1878_CR22
  publication-title: J Am Coll Cardiol
  doi: 10.1016/j.jacc.2015.03.517
  contributor:
    fullname: Y Park
– volume: 2
  issue: 5
  year: 2019
  ident: 1878_CR26
  publication-title: JAMA Netw Open
  doi: 10.1001/jamanetworkopen.2019.4758
  contributor:
    fullname: S Wu
– volume: 383
  start-page: 1068
  issue: 9922
  year: 2014
  ident: 1878_CR17
  publication-title: Lancet
  doi: 10.1016/S0140-6736(13)62154-6
  contributor:
    fullname: SE Kahn
– volume: 15
  start-page: 635
  issue: 5
  year: 2012
  ident: 1878_CR18
  publication-title: Cell Metab
  doi: 10.1016/j.cmet.2012.04.001
  contributor:
    fullname: C Glass
– volume: 18
  start-page: 689
  issue: 10
  year: 2021
  ident: 1878_CR46
  publication-title: Nat Rev Cardiol
  doi: 10.1038/s41569-021-00541-4
  contributor:
    fullname: A Pirillo
– volume: 15
  start-page: 327
  issue: 6
  year: 2019
  ident: 1878_CR9
  publication-title: Nat Rev Nephrol
  doi: 10.1038/s41581-019-0135-6
  contributor:
    fullname: M Kato
– volume: 79
  start-page: 837
  issue: 8
  year: 2022
  ident: 1878_CR21
  publication-title: J Am Coll Cardiol
  doi: 10.1016/j.jacc.2021.12.017
  contributor:
    fullname: L Liberale
SSID ssj0017861
Score 2.4312513
Snippet Both elevated inflammation and atherogenic dyslipidemia are prominent in young-onset diabetes and are increasingly identified as biologically intertwined...
Abstract Background Both elevated inflammation and atherogenic dyslipidemia are prominent in young-onset diabetes and are increasingly identified as...
BackgroundBoth elevated inflammation and atherogenic dyslipidemia are prominent in young-onset diabetes and are increasingly identified as biologically...
BACKGROUNDBoth elevated inflammation and atherogenic dyslipidemia are prominent in young-onset diabetes and are increasingly identified as biologically...
Abstract Background Both elevated inflammation and atherogenic dyslipidemia are prominent in young-onset diabetes and are increasingly identified as...
SourceID doaj
pubmedcentral
proquest
crossref
pubmed
SourceType Open Website
Open Access Repository
Aggregation Database
Index Database
StartPage 181
SubjectTerms Age composition
Age groups
Aging
Antihypertensives
Atherosclerosis - complications
Atherosclerosis - diagnosis
Atherosclerosis - epidemiology
Blood pressure
Body mass index
C-reactive protein
Cohort analysis
Creatinine
Diabetes
Diabetes mellitus (non-insulin dependent)
Diabetes Mellitus, Type 2 - diagnosis
Diabetes Mellitus, Type 2 - epidemiology
Dyslipidemia
Dyslipidemias - diagnosis
Dyslipidemias - epidemiology
Epidemiology
Glucose
Humans
Hypertension
Inflammation
Inflammation - complications
Inflammation - diagnosis
Inflammation - epidemiology
Insulin
Kidney diseases
Lipids
Metabolic disorders
Prospective Studies
Renal function
Risk Factors
Trends
Type 2 diabetes
Variables
Young Adult
Young adults
SummonAdditionalLinks – databaseName: DOAJ Directory of Open Access Journals
  dbid: DOA
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Lb9QwEB6hHhCXikcpKQUNUm_IauL4FW6AqCqkcqGVerOc2Fa5ZKt9HPpL-LuM7WTbrZC4cF1bWccz9nyTmfkG4ER2KkpyflhPtooJFzrmeFRMKx_4MBDgyIXCFz_U-ZX4fi2vH7T6SjlhhR64bNwpGSDFh075OnqhRDQ6OQlGyHbgjesLE2jdzc7UFD_QRjVziYxRp6tk1VK8MuUOGfKb5I4Zymz9f4OYjzMlH5ies-ewP2FG_FzW-gKehPElPL2YouKv4PfPze3SsZQalC4vLDkauIg4FOpbJDUiyZcqRXSjx4z7FqQ8NOjvCGuWRrEOafy-jgrTB1rkOH-gxdyaCO_SDYGZuWP1CR3SC80Fm5ga7i7XmFlrD-Dq7Nvl13M2NVxgg1RizQzXSjjy-FQYZOh7YWQ61LFvtak1586QRRUmBsIwwjdd4LXxXnju4tBo2t3XsDcuxvAGkCb7tiW8IWMnGk7Xe-jrXjnTkQepvKjg47z_9rbwatjsjxhli7QsPc9maVlZwZckou3MxImdfyBNsZOm2H9pSgXHs4DtdFBXltAV_QMnVFvBh-0wHbEUN3FjWGzKHJ78tqaCw6IP25W0OlMY6grMjqbsLHV3ZPx1k2m8mxTU5Voc_Y-XewvPeFZvzRp5DHvr5Sa8I7i07t_nk_EHcDQTBQ
  priority: 102
  providerName: Directory of Open Access Journals
– databaseName: ProQuest Central
  dbid: BENPR
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1Lb9QwELZgKyEuiJZXSosGiRuymjh-hQuiqFVVqRUCKvVmObFNuSTLPg79Jf27jO1kyyLENbYSxzOe-cbzIuSdaGQQaPzQFnUV5dY31LIgqZLOs65DwJEShS8u5dkVP78W1-OF23IMq5xkYhLUbujiHfkRqkGN2gzhx8f5Lxq7RkXv6thC4yHZYWgplDOyc3xy-eXrxo-gtKymVBktj5ZRu0W_ZYwhwtdRsaWOUtX-f0HNvyMm_1BBp0_JkxE7wqdM7F3ywPd75NHF6B1_Ru6-recLS2OIUBRikGM1YAjQ5RK4gOyEHJCzFcH2DhL-G5CJcNDdIubMDWMt4Ph9PhXEi1pgMF3UQmpRBLdRUkCq4LH8ABbwh6bETYiNdxcrSNVrn5Or05Pvn8_o2HiBdkLyFdVMSW7R8pO-E75tuRbxcIe2VrpUjFmNmpXr4BHLcFc1npXaOe6YDV2lcHdfkFk_9P4VAZzs6hpxhwgNrxiKed-WrbS6QUtSOl6Q99P-m3mur2GSXaKlydQy-D6TqGVEQY4jiTYzY23s9GBY_DDjUTMIWSTrGunK4LjkQatoVmou6o5VtsVPHkwENuOBXZp79irI280wHrXoP7G9H9Z5Dov2W1WQl5kfNiupVSplqAqitzhla6nbI_3Pm1TOu4rOXab4_v_X9Zo8ZolxFa3EAZmtFmt_iIBo1b4Zuf4333ENTQ
  priority: 102
  providerName: ProQuest
– databaseName: Scholars Portal Open Access Journals
  dbid: M48
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1LixQxEC7WFZa9iG9bVynBm0QnmbxaEFFxWYT1ogN7C-lOWgXpXntmwPkl_l0r6e5ZR-bktZN-papSX6VeAM9UqRtFxg-rSFcx6WPJvGg0MzpEUdcEOHKi8PknfbaQHy_UxQFM7Y7GBVzuNe1SP6lF_-PFr5-bNyTwr7PAW_1ymXRW8kamyCBLVpG6BteFJEs9hfLJK6-CsZpPiTN77zuGo7nJNenMjp7K5fz3YdB_Qyn_0k2nN-HGCCrx7cAFt-Agtrfh6Hx0m9-B35_Xl71nKXYo7W44BHFg12A91MZF-nNijSGNEX0bMAPDjriLBsOGwOjQSdYjjV8lWmE6wUWB0wku5t5FuElbCObSHstX6JF-aMroxNSRt19hLmt7FxanH768P2NjRwZWKy1XzAqjpSeTUMdaxaqSViWpb6q5sTMjhLekcqVtIoEcGXgZxcyGIIPwTc0NLfQ9OGy7Nj4ApMmBKGS5akrJBe3_sZpV2tuSVl8HWcDzaf3d5VB4w2WDxWo3EM7R81wmnFMFvEsk2s5MRbPzha7_6kYZdIRltKhLHWZNkFo21iR700o1rwX3Fb3yZCKwmxjREfyiNwiCvQU83Q6TDCbHim9jtx7miGTY8QLuD_yw_ZKJnwqwO5yy86m7I-33b7nON09eX2Hkw_-_9REci8zfhnF1Aoerfh0fE4paVU-yaPwB_ckchw
  priority: 102
  providerName: Scholars Portal
Title Supra-additive effect of chronic inflammation and atherogenic dyslipidemia on developing type 2 diabetes among young adults: a prospective cohort study
URI https://www.ncbi.nlm.nih.gov/pubmed/37454077
https://www.proquest.com/docview/2838782656
https://search.proquest.com/docview/2838243991
https://pubmed.ncbi.nlm.nih.gov/PMC10350274
https://doaj.org/article/81262c96d0fd464f8728288453c21ab4
Volume 22
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1La9wwEBZJCqWX0HfcpMsUeivOrmW93FsSEkJhQ2gb2JuQJbkNNPayj0N-Sf9uRrK16ZaeetnDSruWpW-kbzQvQj7ySjQclZ-8xrMqZ8ZXuaGNyKVwnlqLhCMGCk-vxOUN-zLjsx0iUixMdNq39e1x--vuuL39GX0r53d2nPzExtfTsyKYw1CdGu-SXURo0tEH24FUokjhMUqMl-FEC7bK4DekUGcKxWpKGTPPya3TKCbt_xfT_Nth8o8T6OI52R-oI5z0Q3xBdnz7kjydDsbxV-T3t_V8YfLgIRT2MOhdNaBrwPYZcAHRhADogxXBtA4i_esQQ9jo7pFy9vViDWD7YzgVhHtaoJDuaSFWKIL7sFFATOCx_AwG8IVS3CaEuruLFcTkta_JzcX597PLfKi7kFsu2CpXVApmUPET3nJf10zxINtNXUo1kZQahQcrU41HKsNcUXk6Uc4xR01jC4kT_YbstV3rDwhgZ1eWSDt4U7GC4i7v60ktjKpw9oVjGfmU5l_P-_QaOqolSuh-4TT-n44Lp3lGTsMSbXqG1Njxi27xQw8A0chYBLWVcJPGMcEaJYNWqRgvLS1MjY88SgusB3ldaiRZ-ASK5DYjHzbNKGnBfGJa3637PjSob0VG3vZ42Iwk4SkjagspW0PdbkFwx2zeCczv_v-nh-QZjfiWecGPyN5qsfbvkSut6hEKyEyOyJPT86vrr6N444CfU6ZGUWgeAICaGW8
link.rule.ids 230,315,730,783,787,867,888,2109,12068,21400,24330,27936,27937,31731,31732,33756,33757,43322,43817,53804,53806
linkProvider National Library of Medicine
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1Lb9QwELaglYAL4k2gwCBxQ1Y3jl_hgihqtUB3haCVerOc2AEuybKPQ38Jf5cZJ9myCHFdW4k38_rG82LslSp1o9D54RXaKi59LLkXjeZGhyjqGgFHKhSezfX0XH68UBfDhdtqSKscdWJS1KGr6Y78EM2gRWuG8OPt4ienqVEUXR1GaFxn-9SqCp2v_aPj-ecv2ziCsTofS2WsPlyRdaO4JeUQ4eO42jFHqWv_v6Dm3xmTf5igkzvs9oAd4V1P7LvsWmzvsRuzITp-n_36ulksPacUIVJi0OdqQNdA3bfABWQn5IC-WhF8GyDhvw6ZCBfDJWLOfmCsB1y_qqcCuqgFAeNFLaQRRXBJmgJSB4_VG_CAf2gs3AQavLtcQ-pe-4CdnxyfvZ_yYfACr5WWa26F0dKj56djrWJVSatIuJuqMHZihPAWLau0TUQsI0NeRjGxIcggfFPnBr_uQ7bXdm18zAA3h6JA3KGaUuYC1XysJpX2tkRPUgeZsdfj93eLvr-GS36J1a6nlsPnuUQtpzJ2RCTa7qTe2OmHbvnNDaLmELJoUZc6TJogtWysIbfSSlXUIvcVvvJgJLAbBHblrtgrYy-3yyhqFD_xbew2_R5B_luesUc9P2xPUpjUytBkzO5wys5Rd1faH99TO--cgrvCyCf_P9cLdnN6Njt1px_mn56yWyIxseG5OmB76-UmPkNwtK6eDxLwG879EEc
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Jb9QwFLagSBUX9iVQwEjcUGYSx7EdblAYlWWqSlCpEgfLK1TQZDSTOZQ_wt_l2YkHpuLUa-zEsfzZ73t-G0Iv6ob5GpSfXIOsyqlyTa6IZzln1hFjgHDEQOH5ITs4ph9O6pPRq3I1ulW2Rp9O2p9nk_b0e_StXJyZafITmx7N98tgDgN1arqwfnoVXYNNW7CkqY8WBC5YmYJkBJuuglwLFsvgPSRAcwolayoe88_xLZkUU_f_j29edJv8Rw7NbqKvaQaD-8mPybrXE_PrQnLHy03xFrox0lP8euhzG11x7R20Ox8N8HfR78_rxVLlwQspnJN4cAfBncdmyLKLAbEAsiEgEqvW4kgxO8ApNNpzoLVDTVqFof1vyBYOd8GY4HQXjGMVJHweDiMck4SsXmGFYdopNhSH2r7LHscEuffQ8ezdl_2DfKztkJua0T4XhDOqQLlkztROayrqcH54XXFRcEKUAOFNhXdAl6gtG0cKYS21RHlTcljG-2in7Vr3EGHobKsKqE3tG1oSkCROF5op0cDaMksz9DKtrlwMKTxkVH0EkwMsJHxPRljIOkNvAgA2PUP67figW36T4wpJYEWMmIbZwlvKqBc8aK6C1pUhpdIw5F6CjxzPhJUEIgcjECDQGXq-aYbdHEw0qnXdeuhDgopYZujBgLbNnyS0Zkhs4XDrV7dbAF0xY3hC06PLv_oM7R69nclP7w8_PkbXSdxIPC_rPbTTL9fuCVCzXj-Ne_APElY5vA
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Supra-additive+effect+of+chronic+inflammation+and+atherogenic+dyslipidemia+on+developing+type+2+diabetes+among+young+adults%3A+a+prospective+cohort+study&rft.jtitle=Cardiovascular+diabetology&rft.au=Lan%2C+Yulong&rft.au=Wu%2C+Dan&rft.au=Cai%2C+Zhiwei&rft.au=Xu%2C+Yuancheng&rft.date=2023-07-15&rft.pub=BioMed+Central&rft.eissn=1475-2840&rft.volume=22&rft_id=info:doi/10.1186%2Fs12933-023-01878-5&rft_id=info%3Apmid%2F37454077&rft.externalDBID=PMC10350274
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1475-2840&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1475-2840&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1475-2840&client=summon